News Column

Arthur Tzianabos to Join Agilis Biotherapeutics Scientific Advisory Board

June 10, 2014

Agilis Biotherapeutics reported that Arthur Tzianabos has joined its Scientific Advisory Board.

In a release, the Company noted that Tzianabos is currently Chief Scientific Officer of OvaScience, a life sciences company developing new fertility treatments. Prior to OvaScience, Tzianabos was Senior Vice President of Research and Non-Clinical Development at Shire Human Genetic Therapies.

"We are thrilled to welcome Dr. Tzianabos to our Scientific Advisory Board," said Houston Hall, Chairman of Agilis. "Arthur shares our commitment to patients that are suffering from Friedreich's ataxia. He also brings a wealth of experience in developing treatments for rare diseases that will assist us in the development and commercialization of Agilis therapies for this life- threatening disease."

Agilis Biotherapeutics is a biotechnology company.

((Comments on this story may be sent to

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Professional Services Close - Up

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters